Healthcare Services

Hyperhidrosis Treatment Industry Expansion Forecast Showing Market Size of $2.29 Billion by 2030 at 6.7% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Hyperhidrosis Treatment Market Over The Period 2026–2030?

The hyperhidrosis treatment market size has experienced significant expansion in recent years. This market is projected to expand from $1.67 billion in 2025 to $1.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this growth during the historic period include heightened public recognition of hyperhidrosis as a genuine medical issue, the extensive application of aluminum chloride topical solutions, the increasing number of available dermatology clinics, a rise in social unease associated with excessive perspiration, and well-established surgical methods for treatment.

The hyperhidrosis treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This projected growth is primarily driven by factors such as a rising demand for non-surgical treatment options, continuous technological progress in laser therapies, the increasing use of botulinum toxin A injections, the proliferation of home-use medical devices, and improved healthcare accessibility in developing regions. Key trends expected during this forecast period encompass the increasing embrace of botulinum toxin treatments, a growing inclination towards minimally invasive procedures, greater demand for home-based iontophoresis devices, the broadening application of laser and energy-based therapies, and an intensified focus on therapies aimed at enhancing patients’ quality of life.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13171&type=smp

What Underlying Factors Are Accelerating The Growth Of The Hyperhidrosis Treatment Market?

The rising incidence of diabetes mellitus is projected to boost the expansion of the hyperhidrosis treatment market in the future. Diabetes mellitus is defined as a medical state where the body either fails to produce sufficient insulin or reacts improperly to it, leading to abnormally elevated blood sugar (glucose) levels. This condition can harm the nerves regulating sweat glands, consequently causing excessive perspiration or hyperhidrosis. Furthermore, diabetes often hinders an individual’s ability to regulate body temperature consistently and generate the necessary sweat for cooling. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, indicated that more than half a billion individuals worldwide had diabetes. This figure is anticipated to more than double, reaching 1.3 billion people by 2050. Consequently, the growing occurrence of diabetes mellitus is a key driver for the hyperhidrosis treatment market.

How Is The Hyperhidrosis Treatment Market Divided Into Its Major Segments?

The hyperhidrosis treatment market covered in this report is segmented –

1) By Treatment Type: Topical Treatments, Surgical Treatments, Botulin Toxin A, Iontophoresis, Laser Treatments, Other Treatments

2) By Route Of Administration: Oral, Injectable

3) By Disease Type: Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis, Other Diseases

4) By Distribution Channel: Hospitals, Ambulatory Surgical Centers, Retail Pharmacies, Online

Subsegments:

1) By Topical Treatments: Aluminum Chloride Solutions, Antiperspirants

2) By Surgical Treatments: Sympathectomy, Excision

3) By Botulin Toxin A: Injection Treatments, Combination Therapies

4) By Iontophoresis: Home Devices, Clinical Devices

5) By Laser Treatments: Microwave Therapy, Laser Ablation

6) By Other Treatments: Oral Medications, Alternative Therapies

What Key Trends Are Influencing The Development Of The Hyperhidrosis Treatment Market?

Leading companies in the hyperhidrosis treatment market are prioritizing the creation of safer, non-invasive therapies that offer enhanced effectiveness, pushing forward innovations in topical and targeted drug formulations, and conducting clinical trials aimed at providing sustained symptom relief with reduced adverse effects. As an illustration, March 2025 saw the approval of sofpironium gel, a new topical therapy representing a notable leap forward in addressing primary axillary hyperhidrosis, a condition impacting millions across the U.S. This gel functions as a retrometabolic drug, specifically targeting M3 muscarinic receptors within sweat glands to decrease sweating, all while ensuring minimal systemic side effects thanks to its rapid metabolism. Results from Phase 3 trials demonstrated considerable symptom improvement, with patients experiencing relief starting within one week and maintained over the entire six-week study duration. When contrasted with existing topical anticholinergics, sofpironium exhibited a superior safety profile and a reduced incidence of adverse reactions. Furthermore, long-term data validated its sustained efficacy and tolerability, thereby establishing the gel as an effective, non-invasive option for individuals seeking alternatives to their current treatments.

Who Are The Prominent Organizations Shaping The Hyperhidrosis Treatment Market?

Major companies operating in the hyperhidrosis treatment market are Pfizer Inc., AbbVie Inc., Sanofi S.A., AstraZeneca Plc, GSK plc, Teva Pharmaceutical Industries Ltd., Mylan N.V., Cynosure LLC, Ipsen SA, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc, Kaken Pharmaceutical Co Ltd, Avanor Healthcare Ltd., HUGEL Inc., Evolus Inc., Revance Therapeutics Inc., Dermira Inc., Sesderma SL, Miramar Labs Inc., Dermavant Sciences Inc., Theravida Inc., SweatBlock, Brickell Biotech Inc., Fresh Tracks Therapeutics Inc., Advin Health Care Inc, Dermadry Laboratories Inc., Ulthera Inc., Dermata Therapeutics Inc.

Read the full hyperhidrosis treatment market report here:

https://www.thebusinessresearchcompany.com/report/hyperhidrosis-treatment-global-market-report

Which Region Is Projected To Dominate The Hyperhidrosis Treatment Market During The Forecast Period?

North America was the largest region in the hyperhidrosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperhidrosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hyperhidrosis Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13171&type=smp

Browse Through More Reports Similar to the Global Hyperhidrosis Treatment Market 2026, By The Business Research Company

Hyperpigmentation Disorder Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/hyperpigmentation-disorder-treatment-global-market-report

Pigmentation Disorders Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/pigmentation-disorders-treatment-global-market-report

Allergy Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/allergy-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795